Table 2

TGF-β1T+29C and C-509 polymorphisms in association with 5-year overall survival and disease-free survival, Shanghai Breast Cancer Study

GenotypeNo. of subjects%5-yr overall survival5-yr disease-free survival
No. of deaths%Survival rate %PNo. of eventsa%Survival rate %P
TGF-β1 T+29C
TT25823.23519.487.53917.085.2
TC55349.89753.983.512755.277.0
CC30027.04826.783.60.306427.878.30.04
TT25023.13519.487.53917.085.2
TC/CC83276.914580.683.50.1519183.077.50.01
TGF-β1 C-509T
CC25723.33519.887.53917.285.1
TC55150.09453.184.012454.677.5
TT29426.74827.183.30.396428.277.80.05
CC25723.33519.887.53917.285.1
TC/TT94576.714280.283.70.1818882.877.60.02
  • a Including relapse, metastasis, and breast cancer death.